Germany's DAX Index Blinks Green; Bayer Gains on New Regulatory Win

11:57 AM EST, 12/23/2025 (MT Newswires) -- The blue-chip DAX Index ended Tuesday 0.23% in the green, with trading volumes expected to remain light in the lead-up to Christmas. Import prices in Germany fell 1.9% year over year in November 2025, following a 1.4% decline in the previous month, government data showed. The latest reading marks the largest annual decrease recorded for import prices since March 2024. On a monthly basis, import prices were 0.5% higher. "Once again, the decrease in energy prices, at -15.7% compared with November 2024, had the biggest impact on the overall development of import prices in November 2025. Compared with October 2025, however, energy prices rose by 3.1% on average," Destatis said. On the corporate front, Bayer (BAYN.F) secured approval from Japan's Ministry of Health, Labour and Welfare for its finerenone drug to treat chronic heart failure in adult patients with a left ventricular ejection fraction of at least 40%. The approval for the new indication is based on positive results from the late-stage Finearts-HF study. The biopharmaceutical company closed the session 1.07% higher. Meanwhile, Mercedes-Benz Group (MBG.F) reached a deal with several US states, agreeing to pay an initial total settlement worth $120 million to resolve civil environmental and consumer protection claims tied to emission control systems of certain diesel passenger car and van models in the US. The German automaker's stock edged up 0.12% at closing. "With the settlements, Mercedes-Benz is taking another important step toward resolution of various diesel proceedings. The company is thus resolving all material remaining legal proceedings related to diesel emissions in the U.S.," the automaker noted. "While the company has cooperated fully with the state attorneys general, Mercedes-Benz continues to regard the accusations made as unfounded and denies any liability to the U.S. states or otherwise."